ImmuPharma appoints new adviser
ImmuPharma has appointed Northland Capital Partners as its Nominated Adviser and sole broker with immediate effect. ImmuPharma is a pharmaceutical…
Pharmaceuticals, Biotechnology and Life Sciences
ImmuPharma has appointed Northland Capital Partners as its Nominated Adviser and sole broker with immediate effect. ImmuPharma is a pharmaceutical…
A swedish oncology company Oasmia Pharmaceutical AB, which works on finding cancer cures for animals and humans, said it would move its veterinary assets to the United States.
STADA Arzneimittel AG has named Dr. Barthold Piening as a full Member of the Executive Board with effect from July 1, 2017.
Alliance Pharma’s revenue for 2016, driven by the acquisition of ex-Sinclair products in December 2015, could be more than double compared to the previous year.
Oxford BioDynamics (OBD) has entered into a pilot development agreement with EpiFit PTE. LTD., (EpiFit), a new Singapore based company, to identify epigenetic biomarkers to evaluate predispositions, variations and responses in healthy volunteers undergoing fitness programmes conducted by EpiFit.
Consort Medical, a single source drug and delivery device company, has participated in a further equity raise by Atlas Genetics Ltd.
Cellectis’s scinetists lead by Dr Alexandre Juillerat have designed a new CAR architecture that contains an integrated microenvironment sensor. Their work was recently published in a scientific magazine “Scientific Reports”.
Mereo BioPharma said on Monday that all three of its submitted abstracts have been accepted for presentation as posters at the American Thoracic Society meeting in Washington, 19-24 May 2017.
Xintela AB has reported positive results in its two main projects in regenerative medicine and cancer.
Flu, or influenza, is a very contagious, acute, viral respiratory infection. Influenza viruses vary in a high degree. The extent…